FFAR2 and graft versus host disease: The binding of butyrate and propionate to the G protein-coupled receptor 43 (GPR43) receptor on intraepithelial cells (IECs) alone was sufficient to reduce intestinal permeability and alleviate GVHD in one preclinical murine model (80).